ASCO 2024 lung cancer WC

CME

Conference to Clinic: Lung Cancer
Credits Available

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: July 02, 2024

Expiration: July 01, 2025

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Which of the following findings was reported from the phase III ADRIATIC trial comparing durvalumab vs placebo as consolidation therapy in patients with LS-SCLC without PD following SoC concurrent chemoradiotherapy?

2.

How often do you currently test patients with unresectable stage IIIA-IIIC NSCLC for actionable EGFR mutations?